Last week also saw the Gates Foundation and Gavi, the Vaccine Alliance doubling their funding to the Indian Serum Institute in[ ... ]
Overview
Fair and equitable access to Health Care Technologies (HTCs), such as Personal Protective Equipment, Diagnostics, Treatments and Vaccines are vital to a proper global health response to the COVID-19 Pandemic. This applies equally to related and context-specific Research and Development.
Recent in Access and R&D
The U.S. FDA last month approved an Emergency Use Authorization for Remdesivir, an experimental broad-spectrum antiviral. Initially developed by Gilead Sciences[ ... ]
Astra Zeneca and Oxford University resumed clinical trials for AZD1222, considered among the most promising COVID-19 vaccine candidate. The Phase 3[ ... ]
Resources
The latest scientific findings and knowledge on COVID-19 compiled by the WHO [ ... ]
he Foundation for Innovative New Diagnostics (FIND) is a WHO Collaborating Centre [ ... ]
Curation of all known tests commercially available or in development for the [ ... ]
Diagnostic use cases for SARS-CoV-2 tests, highlighting the comparison, contrast and implications [ ... ]
This document presents a Global Research Roadmap with immediate, mid-term and longer-term [ ... ]